Breast cancer imaging method uses fluorescent nanoparticles, NIR light

SEPTEMBER 26, 2008 -- Scientists from Penn State University have developed a new bioimaging method for breast cancer. Their research uses encapsulated fluorescent molecules in calcium phosphate nanoparticles and non-toxic near infrared (NIR) imaging. The nanoparticles, containing the NIR fluorescing dye indocyanine green, enabled detection of 5mm diameter breast cancer tumors in a live mouse model over a period of four or more days.

Sep 26th, 2008

SEPTEMBER 26, 2008 -- Scientists from various groups within Penn State University have developed a new method of imaging breast cancer.

Their research uses encapsulated fluorescent molecules in calcium phosphate nanoparticles and non-toxic near infrared (NIR) imaging. The nanoparticles, containing the NIR fluorescing dye indocyanine green, enabled detection of 5mm diameter breast cancer tumors in a live mouse model over a period of four or more days.
Indocyanine green is the only NIR organic dye approved by the Food and Drug Administration (FDA) for use in the human body. The nanoparticles, which are around 20 nm in diameter—one five thousandth the diameter of a human hair—are made of calcium phosphate, a biocompatible material that has long been used as a bone replacement. Unlike other nanoparticles considered for imaging and drug delivery, e.g., semiconductor quantum dots, the biodegradable components of calcium phosphate nanoparticles are already widely present in the bloodstream.

The team of scientists draws from the Penn State Milton S. Hershey Medical Center, Penn State College of Medicine, and Penn State's departments of Materials Science and Engineering and Physics. They say their technique is a noninvasive, painless, and non-ionizing form of radiation that operates at wavelengths just above that of visible light.

In addition to the combination of near infrared bioimaging and nanoparticles, a second innovation is the development of a fundamentally new method for processing nanoparticulates. The process is called van der Waals HPLC (high performance liquid chromatography). Materials scientist Jim Adair, whose team synthesized the particles, says "Our technique takes advantage of the large van der Waals forces associated with particles, as opposed to the small van der Waals forces associated with molecules, atoms, and ions. The hard part in the synthesis was making sure the particles did not clump together. The critical stage was the laundering of all the nonessential byproducts associated with the synthesis. By the end, we had a very clean suspension of particles in which all the spectator ions, molecules, and atoms had been washed away from the basic nanoparticles."

The Hershey group, led by pharmacologist Mark Kester, showed that their nanoparticles provide the fluorescent dye with 200% greater photoefficiency compared to indocynine green injected into the bloodstream, with a 500% greater photostability. In a separate experiment discussed in the paper, the researchers were able to image through 3cm of dense pig muscle tissue, which should correlate to at least 10 cm, and likely much deeper, in patients, according to Adair.

The research is described in the Sept. issue of ACS Nano.

More information
ACS Nano article abstract

More in Biomedicine